• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次或主要免疫。一、对不相关同种异体抗原的同时细胞溶解性T细胞反应的抑制。

A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens.

作者信息

Rowley D A, Stach R M

机构信息

Department of Pathology, University of Chicago, Illinois 60637.

出版信息

J Exp Med. 1993 Sep 1;178(3):835-40. doi: 10.1084/jem.178.3.835.

DOI:10.1084/jem.178.3.835
PMID:8350057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2191159/
Abstract

A first or dominant immunization with one antigen markedly inhibited specific cytolytic T lymphocyte (CTL) responses to a second unrelated alloantigen without suppressing antibody responses to other antigens. Suppression was induced rapidly, became systemic, and could be transferred passively with only serum. Suppression did not result from elimination of cells capable of responding to the second antigen. The mechanisms responsible for this "priority of the first response" may be the same that help protect the fetus during pregnancy, promote renal allograft survival after multiple blood transfusions, and prevent effective CTL-mediated immunity to variants of tumor cells or infectious agents that arise during tumor progression or chronic infections.

摘要

首次或用一种抗原进行主要免疫时,会显著抑制针对第二种不相关同种异体抗原的特异性细胞毒性T淋巴细胞(CTL)反应,而不会抑制对其他抗原的抗体反应。抑制作用迅速诱导产生,成为全身性的,并且仅通过血清就能被动转移。抑制并非由于能够对第二种抗原作出反应的细胞被清除所致。导致这种“首次反应优先”的机制可能与孕期保护胎儿、多次输血后促进肾移植存活以及防止对肿瘤进展或慢性感染期间出现的肿瘤细胞或传染因子变体产生有效的CTL介导免疫的机制相同。

相似文献

1
A first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigens.首次或主要免疫。一、对不相关同种异体抗原的同时细胞溶解性T细胞反应的抑制。
J Exp Med. 1993 Sep 1;178(3):835-40. doi: 10.1084/jem.178.3.835.
2
A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens.首次或主要免疫。二、诱导产生的免疫球蛋白携带转化生长因子β并抑制细胞溶解性T细胞对无关同种异体抗原的反应。
J Exp Med. 1993 Sep 1;178(3):841-52. doi: 10.1084/jem.178.3.841.
3
Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.抑制性T细胞不同于“否决细胞”,它由同种异体抗原引发诱导产生,并在体内介导对细胞毒性T淋巴细胞反应的可转移抑制作用。
J Immunol. 1985 Nov;135(5):2984-9.
4
Blood-transfusion-induced suppression of cytotoxic T lymphocyte responses in mice.输血诱导的小鼠细胞毒性T淋巴细胞反应抑制
Transplantation. 1983 Nov;36(5):520-5. doi: 10.1097/00007890-198311000-00010.
5
Alloantigen pretreatment induces a down-regulation of the in vivo subsequent development of cytotoxic T lymphocytes directed against linked alloantigens.
Eur J Immunol. 1989 Aug;19(8):1365-71. doi: 10.1002/eji.1830190803.
6
Protection against metastasis by immunization with an allogeneic lymphocyte antigen.通过同种异体淋巴细胞抗原免疫来预防转移。
Cancer Immunol Immunother. 1995 Dec;41(6):384-8. doi: 10.1007/BF01526558.
7
Detection in vivo 6 hours after immunization of a mediator with possible antisuppressor activity.
Eur J Immunol. 1983 Oct;13(10):799-804. doi: 10.1002/eji.1830131004.
8
Cloned cytolytic T cells can suppress primary cytotoxic responses directed against them.克隆化的细胞溶解T细胞能够抑制针对它们的原发性细胞毒性反应。
J Immunol. 1984 Oct;133(4):1775-81.
9
Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.同种抗原耐受性诱导的研究。II. 通过门静脉接种异基因细胞产生能够传递迟发型超敏反应同种抗原特异性耐受性的血清因子。
J Immunol. 1986 Apr 15;136(8):2763-8.
10
Alloantigen-specific regulation of cytotoxic T cell responses is mediated through the induction of clonal anergy of CD8+ T cells.
Eur J Immunol. 1992 Feb;22(2):387-92. doi: 10.1002/eji.1830220215.

引用本文的文献

1
Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.新辅助 PD-1 免疫检查点阻断逆转肿瘤抗原特异性 T 细胞的功能优势。
Clin Cancer Res. 2020 Feb 1;26(3):679-689. doi: 10.1158/1078-0432.CCR-19-2209. Epub 2019 Oct 23.
2
Circulating immunoglobulin-bound transforming growth factor beta at a late tumour-bearing stage impairs antigen-specific responses of CD4+ T cells.在肿瘤晚期,循环免疫球蛋白结合的转化生长因子β会损害CD4 + T细胞的抗原特异性反应。
Clin Exp Immunol. 2002 May;128(2):204-12. doi: 10.1046/j.1365-2249.2002.01806.x.
3
T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.人类免疫缺陷病毒1特异性细胞毒性T淋巴细胞克隆的T细胞受体使用情况及精细特异性:准种识别分析揭示针对一种体内次要变异体的主要应答。
J Exp Med. 1996 Apr 1;183(4):1669-79. doi: 10.1084/jem.183.4.1669.
4
A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens.首次或主要免疫。二、诱导产生的免疫球蛋白携带转化生长因子β并抑制细胞溶解性T细胞对无关同种异体抗原的反应。
J Exp Med. 1993 Sep 1;178(3):841-52. doi: 10.1084/jem.178.3.841.
5
Autoantibodies produced spontaneously by young 1pr mice carry transforming growth factor beta and suppress cytotoxic T lymphocyte responses.年轻的1pr小鼠自发产生的自身抗体携带转化生长因子β并抑制细胞毒性T淋巴细胞反应。
J Exp Med. 1995 May 1;181(5):1875-80. doi: 10.1084/jem.181.5.1875.

本文引用的文献

1
Leucocyte antibodies in sera from pregnant women.孕妇血清中的白细胞抗体。
Nature. 1958 Jun 21;181(4625):1735-6. doi: 10.1038/1811735a0.
2
A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens.首次或主要免疫。二、诱导产生的免疫球蛋白携带转化生长因子β并抑制细胞溶解性T细胞对无关同种异体抗原的反应。
J Exp Med. 1993 Sep 1;178(3):841-52. doi: 10.1084/jem.178.3.841.
3
Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells.同基因肿瘤排斥的机制。宿主选择的进展性变体对各种免疫效应细胞的敏感性。
J Exp Med. 1982 Feb 1;155(2):557-73. doi: 10.1084/jem.155.2.557.
4
Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans.主要组织相容性复合体抗原、母体和父体免疫反应与人类习惯性流产
Am J Obstet Gynecol. 1981 Dec 15;141(8):987-99. doi: 10.1016/s0002-9378(16)32690-4.
5
Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory.表位特异性调节。II. 一种双稳态、受免疫球蛋白重链(Igh)限制的调节机制,是免疫记忆的核心。
J Exp Med. 1982 Jun 1;155(6):1741-53. doi: 10.1084/jem.155.6.1741.
6
Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses.表位特异性调节。I. 针对IgG抗半抗原抗体应答的载体特异性抑制诱导。
J Exp Med. 1982 Jun 1;155(6):1730-40. doi: 10.1084/jem.155.6.1730.
7
Prevention of recurrent abortion with leucocyte transfusions.白细胞输注预防复发性流产。
Lancet. 1981 Jul 11;2(8237):68-70. doi: 10.1016/s0140-6736(81)90413-x.
8
Further improvements in the plaque technique for detecting single antibody-forming cells.用于检测单个抗体形成细胞的蚀斑技术的进一步改进。
Immunology. 1968 Apr;14(4):599-600.
9
Antigenic competition between polypeptidyl determinants in normal and tolerant rabbits.正常和耐受兔中多肽基决定簇之间的抗原竞争
J Exp Med. 1968 Feb 1;127(2):237-50. doi: 10.1084/jem.127.2.237.
10
Antigen competition: antigens compete for a cell occurring with limited frequency.抗原竞争:抗原竞争有限频率出现的细胞。
Science. 1970 Jan 9;167(3915):196-8. doi: 10.1126/science.167.3915.196.